SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIMONDI, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.869
AS - Asia 3.071
EU - Europa 1.794
SA - Sud America 492
AF - Africa 75
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.736
SG - Singapore 1.193
CN - Cina 719
IT - Italia 507
BR - Brasile 384
VN - Vietnam 347
DE - Germania 258
HK - Hong Kong 254
PL - Polonia 212
UA - Ucraina 178
GB - Regno Unito 173
TR - Turchia 135
FI - Finlandia 99
FR - Francia 83
JP - Giappone 81
RU - Federazione Russa 74
IN - India 73
CA - Canada 70
ID - Indonesia 65
BD - Bangladesh 59
SE - Svezia 57
AR - Argentina 41
MX - Messico 36
ZA - Sudafrica 33
NL - Olanda 29
IQ - Iraq 28
ES - Italia 27
BE - Belgio 20
VE - Venezuela 19
PK - Pakistan 18
CZ - Repubblica Ceca 15
EC - Ecuador 13
SA - Arabia Saudita 13
LT - Lituania 12
MY - Malesia 12
UZ - Uzbekistan 12
AT - Austria 11
CO - Colombia 11
AE - Emirati Arabi Uniti 9
KG - Kirghizistan 9
MA - Marocco 9
EG - Egitto 8
RO - Romania 8
CL - Cile 7
KE - Kenya 7
AU - Australia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
AZ - Azerbaigian 5
IL - Israele 5
JM - Giamaica 5
TN - Tunisia 5
UY - Uruguay 5
DZ - Algeria 4
HN - Honduras 4
PH - Filippine 4
RS - Serbia 4
CR - Costa Rica 3
DK - Danimarca 3
HR - Croazia 3
IR - Iran 3
KR - Corea 3
NP - Nepal 3
PT - Portogallo 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GE - Georgia 2
GP - Guadalupe 2
GR - Grecia 2
IE - Irlanda 2
LB - Libano 2
LV - Lettonia 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 11.304
Salva come PNG Salva come JPEG
Città #
Ashburn 724
Singapore 717
Fairfield 533
Woodbridge 487
San Jose 424
Houston 283
Beijing 253
Santa Clara 252
Hong Kong 246
Seattle 231
Chandler 218
Warsaw 209
Ann Arbor 203
Dallas 200
Wilmington 197
Jacksonville 190
Cambridge 187
Ferrara 187
Council Bluffs 131
New York 129
Ho Chi Minh City 126
Los Angeles 108
Munich 79
Hanoi 78
Tokyo 76
Izmir 64
Princeton 59
Lauterbourg 54
Jakarta 53
São Paulo 48
Nanjing 47
Milan 42
San Diego 42
Shanghai 37
Helsinki 36
Boardman 35
London 31
Bologna 27
Buffalo 27
Montreal 26
Denver 25
Orem 25
Chicago 23
Johannesburg 22
Chennai 21
Frankfurt am Main 20
Nanchang 20
Falls Church 19
Manchester 19
Atlanta 18
Brussels 17
Da Nang 17
Hefei 17
Tianjin 17
Boston 16
Mexico City 16
Shenyang 16
Turku 16
Dearborn 15
Dong Ket 15
Poplar 15
Rome 15
Brooklyn 14
Haiphong 14
The Dalles 14
Toronto 14
Baghdad 13
Moscow 13
Rio de Janeiro 13
Ankara 12
Nuremberg 12
San Francisco 12
Tashkent 12
Ferrara di Monte Baldo 11
Lappeenranta 11
Brno 10
Stockholm 10
Auburn Hills 9
Bishkek 9
Campinas 9
Hebei 9
Jiaxing 9
Mumbai 9
San Mateo 9
Bremen 8
Caracas 8
Changsha 8
Columbus 8
Falkenstein 8
Guangzhou 8
Norwalk 8
Riyadh 8
Secaucus 8
Washington 8
Zhengzhou 8
Charlotte 7
Dhaka 7
Hải Dương 7
Istanbul 7
Kunming 7
Totale 7.871
Salva come PNG Salva come JPEG
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 275
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 271
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 265
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 252
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 249
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 236
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 229
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 229
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 220
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 215
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 210
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 208
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 205
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 204
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 203
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 203
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 197
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 197
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 188
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 187
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 182
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 177
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 177
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 176
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 173
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 168
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 168
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 166
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 165
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 165
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 164
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 163
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 157
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 156
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 156
Role of vitamin D in the pathogenesis of atheromatosis 156
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 155
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 147
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 145
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 145
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 143
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 139
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 139
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 138
TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release 137
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 137
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 135
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 131
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 129
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 119
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 118
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 117
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 103
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 100
MitoQ is able to modulate apoptosis and inflammation 100
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 95
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 93
null 92
null 90
null 90
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 89
null 88
null 86
null 83
The role of the mTOR pathway in diabetic retinopathy 82
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 77
null 76
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 71
null 69
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 61
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study 57
null 55
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 46
null 44
null 42
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 29
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 28
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 23
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 9
Totale 11.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.476
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 0 44
2021/2022615 28 54 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/20251.604 42 30 132 90 210 126 56 83 306 146 218 165
2025/20264.895 463 283 421 560 693 301 581 284 463 596 244 6
Totale 11.497